Amplification of the MET gene inhibits STING-mediated immunogenicity by up-regulating the expression of CD73 and reduces the response of EGFR-mutant lung cancer to immunotherapy (Yoshida et al., 2022). The gene discussed is STING1; the disease is lung carcinoma.